What smart money is saying about BeOne Medicines
1 fund in our archive has pitched BeOne Medicines — most recently Artisan Non US Small Mid Growth Strategy in June 2025.
BeiGene Ltd. is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.
Get an email when a fund writes about it
Fund coverage · 1 thesis
- Artisan Non US Small Mid Growth StrategyJune 2025
BeOne Medicines is an innovative biopharmaceutical company with a strong commercial portfolio, including the blockbuster drug BRUKINSA® and a promising pipeline of oncology treatments.
Read the full thesis
Read every full thesis on BeOne Medicines
Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→